FDA.reportPublic FDA data

netarsudil 0.02 % Ophthalmic Solution

RxCUI
1992868
RxNorm name
netarsudil 0.02 % Ophthalmic Solution
Display name
netarsudil 0.02 % Ophthalmic Solution
Full name
netarsudil 0.02 % Ophthalmic Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RhopressaNETARSUDILAlcon Laboratories, Inc.7d4f0e3a-5b86-4c43-982a-813b22ae7e222026-01-20Warnings, Adverse reactionsExact identifier
rxcui: 1992868

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7d4f0e3a-5b86-4c43-982a-813b22ae7e22netarsudil 0.02 % Ophthalmic Solution [PSN] · netarsudil 0.2 MG/ML Ophthalmic Solution [SCD] · netarsudil 0.02 % Ophthalmic Solution [SY] · netarsudil 0.2 MG/ML (as netarsudil dimesylate 0.28 MG/ML) Ophthalmic Solution [SY]417These highlights do not include all the information needed to use RHOPRESSA ® safely and effectively. See full prescribing information for RHOPRESSA ® . RHOPRESSA ® (netarsudil ophthalmic solution) 0.02%, for topical ophthalmic use Initial U.S. Approval: 201720260120